v3.26.1
CONDENSED BALANCE SHEETS - USD ($)
Feb. 28, 2026
Nov. 30, 2025
Current assets    
Cash equivalents $ 3,741,247
Total Assets 3,741,247
Deferred offering costs 249,594 32,300
Total Assets 3,990,841 32,300
Current liabilities    
Accrued expenses 8,980 7,247
Accrued offering costs 101,422 7,300
Advances from related party 3,776,471
Promissory note – related party 173,808
Total Liabilities 4,060,681 14,547
Commitments and Contingencies (Note 6)
Shareholder’s Equity (Deficit)    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of February 28, 2026 and November 30, 2025
Additional paid-in capital 24,233 24,233
Accumulated deficit (94,840) (7,247)
Total Shareholder’s Equity (Deficit) (69,840) 17,753
Total Liabilities and Shareholder’s Equity (Deficit) 3,990,841 32,300
Class A Ordinary Shares [Member]    
Shareholder’s Equity (Deficit)    
Ordinary shares, value
Class B Ordinary Shares [Member]    
Shareholder’s Equity (Deficit)    
Ordinary shares, value [1] $ 767 $ 767
[1] Includes 1,000,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On March 2, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, the 1,000,000 Founder Shares are no longer subject to forfeiture (Note 7).